Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (AVess FIH)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 5, 2018

Primary Completion Date

February 19, 2020

Study Completion Date

July 24, 2024

Conditions

Hemodialysis Access Failure

Interventions

DEVICE

SurVeil Drug Coated Balloon

Angioplasty procedure with a paclitaxel-coated, percutaneous transluminal angioplasty (PTA) balloon catheter.

Trial Locations (2)

Auckland City Hospital, Auckland

Prince of Wales Private Hospital, Randwick

All Listed Sponsors

lead

SurModics, Inc.

INDUSTRY

NCT03734679 - Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (AVess FIH) | Biotech Hunter | Biotech Hunter